KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IAC (IAC) Asset Writedowns and Impairment (2020 - 2023)

Historic Asset Writedowns and Impairment for IAC (IAC) over the last 4 years, with Q2 2023 value amounting to $13.8 million.

  • IAC's Asset Writedowns and Impairment fell 812.6% to $13.8 million in Q2 2023 from the same period last year, while for Jun 2023 it was $146.2 million, marking a year-over-year increase of 20424.21%. This contributed to the annual value of $80.8 million for FY2020, which is 2288.7% up from last year.
  • Per IAC's latest filing, its Asset Writedowns and Impairment stood at $13.8 million for Q2 2023, which was down 812.6% from $58.7 million recorded in Q1 2023.
  • IAC's Asset Writedowns and Impairment's 5-year high stood at $62.7 million during Q4 2020, with a 5-year trough of $5.5 million in Q3 2021.
  • For the 4-year period, IAC's Asset Writedowns and Impairment averaged around $23.6 million, with its median value being $13.8 million (2022).
  • Examining YoY changes over the last 5 years, IAC's Asset Writedowns and Impairment showed a top increase of 32730.39% in 2023 and a maximum decrease of 812.6% in 2023.
  • Quarter analysis of 4 years shows IAC's Asset Writedowns and Impairment stood at $62.7 million in 2020, then tumbled by 91.17% to $5.5 million in 2021, then skyrocketed by 172.26% to $15.1 million in 2022, then dropped by 8.13% to $13.8 million in 2023.
  • Its Asset Writedowns and Impairment was $13.8 million in Q2 2023, compared to $58.7 million in Q1 2023 and $15.1 million in Q2 2022.